Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Revenue

Suzhou Highfine Biotech had revenue of 210.53M CNY in the quarter ending September 30, 2026, with 28.06% growth. This brings the company's total for the last twelve months to 757.31M, up 35.62% year-over-year. In the year 2025, Suzhou Highfine Biotech had annual revenue of 602.26M with 33.28% growth. That makes Suzhou Highfine Biotech the 21,723rd largest company in the world by revenue and 3,983rd in China.

• Revenue (ttm): 757.31M
• Revenue Growth: +35.62%
• P/S Ratio: 7.80
• Revenue / Employee: 1.12M
• Employees: 678
• Market Cap: 5.74B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 436.00M 72.4%
• Export 166.26M 27.6%

Fiscal year ended Dec 31, 2025 See the full Suzhou Highfine Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	602.26M	150.39M	33.28%
Dec 31, 2024	451.87M	63.08M	16.22%
Dec 31, 2023	388.79M	-58.66M	-13.11%
Jan 1, 2023	447.46M	78.02M	21.12%
Dec 31, 2021	369.44M	87.09M	30.85%

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error